Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compugen | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪500.51M | 85.3x | 0.84 | ILA 554.50 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lineage Cell Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪472.98M | -5.5x | -0.33 | ILA 214.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oramed Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪362.55M | 22.8x | 0.17 | ILA 893 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Batm | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪361.48M | -227.9x | 1.36 | ILA 81.90 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonus Biogroup | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪124.97M | -2.5x | ILA 10.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Pluri Inc | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪106.39M | -1.3x | -0.05 | ILA 1,905 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Group TR | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪104.32M | 6.9x | 0.02 | ILA 84.80 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLine RX | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪94.79M | -1.3x | -0.02 | ILA 7.90 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enlivex | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪84.34M | -1.1x | -0.06 | ILA 399 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XTL Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪80.28M | -17.6x | -0.67 | ILA 6.40 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Purple Biotech | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪76.83M | -1.1x | -0.01 | ILA 16.50 | 27.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Matricelf | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪62.72M | ILA 397 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Kadimastem Ltd | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪53.64M | -30.2x | -0.06 | ILA 1,279 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evogene | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪39.39M | -0.4x | -0.11 | ILA 579.90 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nextage Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪26.89M | ILA 79.80 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Merchavia | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪11.09M | -1.2x | -0.31 | ILA 66 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hadasit Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪5.17M | -0.7x | -0.01 | ILA 46.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Univo Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ₪2.84M | ILA 93,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |